-
1
-
-
84857065474
-
Discrediting the monoamine hypothesis
-
Hinz M, Stein A, Uncini T. Discrediting the monoamine hypothesis. Int J Gen Med. 2012;5:135-142.
-
(2012)
Int J Gen Med.
, vol.5
, pp. 135-142
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
2
-
-
78650564868
-
The dual-gate lumen model of renal monoamine transport
-
Hinz M, Stein A, Uncini T. The dual-gate lumen model of renal monoamine transport. Neuropsychiatr Dis Treat. 2010;6:387-392.
-
(2010)
Neuropsychiatr Dis Treat.
, vol.6
, pp. 387-392
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
3
-
-
78650579251
-
Amino acid-responsive Crohn's disease: A case study
-
Hinz M, Stein A, Uncini T. Amino acid-responsive Crohn's disease: a case study. Clin Exp Gastroenterol. 2010;3:171-177.
-
(2010)
Clin Exp Gastroenterol.
, vol.3
, pp. 171-177
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
4
-
-
79951602270
-
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
-
Hinz M, Stein A, Uncini T. Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation Neuropsychiatr Dis Treat. 2011;7:31-38.
-
(2011)
Neuropsychiatr Dis Treat
, vol.7
, pp. 31-38
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
5
-
-
79952940164
-
Urinary neurotransmitter testing: Considerations of spot baseline norepinephrine and epinephrine
-
Hinz M, Stein A, Uncini T. Urinary neurotransmitter testing: considerations of spot baseline norepinephrine and epinephrine. Open Access Journal of Urology. 2011;3:19-24.
-
(2011)
Open Access Journal of Urology.
, vol.3
, pp. 19-24
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
6
-
-
84897366608
-
Amino acid management of Parkinson's disease: A case study
-
Hinz M, Stein A, Uncini T. Amino acid management of Parkinson's disease: A case study. Int J Gen Med. 2011;4:1-10.
-
(2011)
Int J Gen Med.
, vol.4
, pp. 1-10
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
7
-
-
80955150233
-
Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model"
-
Hinz M, Stein A, Uncini T. Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model". Int J Nephrol Renovasc Dis. 2011;4:101-113.
-
(2011)
Int J Nephrol Renovasc Dis.
, vol.4
, pp. 101-113
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
8
-
-
80955139861
-
APRESS: Apical regulatory super system, serotonin, and dopamine interaction
-
Hinz M, Stein A, Uncini T. APRESS: apical regulatory super system, serotonin, and dopamine interaction. Neuropsychiatr Dis Treat. 2011; 7:1-7.
-
(2011)
Neuropsychiatr Dis Treat.
, vol.7
, pp. 1-7
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
9
-
-
78650532725
-
Depression
-
In: Kohlstadt I, editor, Boca Raton, FL: CRC Press
-
Hinz M. Depression. In: Kohlstadt I, editor. Food and Nutrients in Disease Management. Boca Raton, FL: CRC Press; 2009.
-
(2009)
Food and Nutrients in Disease Management
-
-
Hinz, M.1
-
10
-
-
70449732260
-
Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population
-
Trachte G, Uncini T, Hinz M. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population. Neuropsychiatr Dis Treat. 2009;5:227-235.
-
(2009)
Neuropsychiatr Dis Treat.
, vol.5
, pp. 227-235
-
-
Trachte, G.1
Uncini, T.2
Hinz, M.3
-
12
-
-
79951636529
-
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
-
Hinz M, Stein A, Uncini T. A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole. Neuropsychiatr Dis Treat. 2010;6:741-747.
-
(2010)
Neuropsychiatr Dis Treat.
, vol.6
, pp. 741-747
-
-
Hinz, M.1
Stein, A.2
Uncini, T.3
-
14
-
-
84877143417
-
-
CMTA Charcot-Marie-Tooth Association [homepage on the Internet], Available from, Accessed February 12
-
CMTA Charcot-Marie-Tooth Association [homepage on the Internet]. Glenolden, PA: Charcot-Marie-Tooth Association; 2006-2011. Available from: http://www.cmtausa.org/index.php?optionfcom_con tent&viewtarticle&ida68&Itemid642. Accessed February 12, 2012.
-
(2012)
Glenolden, PA: Charcot-Marie-Tooth Association; 2006-2011
-
-
-
15
-
-
0031824347
-
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine
-
Andreas B, Ulrich K, Dagar M, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998;54:342-352.
-
(1998)
Mol Pharmacol.
, vol.54
, pp. 342-352
-
-
Andreas, B.1
Ulrich, K.2
Dagar, M.3
-
16
-
-
84877153920
-
-
Food and Nutrition Information Center [homepage on the Internet], Available from, Accessed February 12
-
Food and Nutrition Information Center [homepage on the Internet]. USDA National Agricultural Library; updated 2012. Available from: http://fnic.nal.usda.gov/nal_display/index.php?info_centerh4&tax_ levell1&tax_subjectt620. Accessed February 12, 2012.
-
(2012)
USDA National Agricultural Library; updated 2012
-
-
-
17
-
-
66449087083
-
Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule
-
Wing-Kee L, Markus R, Bayram E, et. al. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. Am J Physiol Renal Physiol. 2009;296:F1504-F1513.
-
(2009)
Am J Physiol Renal Physiol.
, vol.296
-
-
Wing-Kee, L.1
Markus, R.2
Bayram, E.3
|